First Allied Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History

First Allied Advisory Services’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$214K	Buy
2018 Q4	–	Sell
2018 Q3	$355K	Sell
2018 Q2	$1.43M	Sell
2018 Q1	$2.69M	Buy